Cargando…

Reversible Restrictive Lung Disease in Pseudomesotheliomatous Carcinoma in a Lung Harboring a HER2-mutation

Pseudomesotheliomatous carcinoma of the lung is very rare, and reversible restrictive lung disease with pseudomesotheliomatous carcinoma has not yet been previously reported. We herein report a patient with HER2-positive non-small-cell lung cancer (NSCLC) showing pseudomesotheliomatous carcinoma who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakata, Shinya, Sakamoto, Yasumiko, Takaki, Akira, Ishizuka, Shiho, Saeki, Sho, Fujii, Kazuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120847/ https://www.ncbi.nlm.nih.gov/pubmed/29526969 http://dx.doi.org/10.2169/internalmedicine.9612-17

Ejemplares similares

Small-cell Lung Cancer Associated with SAPHO Syndrome
por: Imamura, Kosuke, et al.
Publicado: (2017)

Pseudomesotheliomatous carcinoma of the lung in the parietal pleura
por: An, Ae Ri, et al.
Publicado: (2020)

Fatal Hemothorax Caused by Pseudomesotheliomatous Carcinoma of the Lung
por: Snaebjornsson, Petur, et al.
Publicado: (2011)

Pseudomesotheliomatous carcinoma of lung adenocarcinoma diagnosed using transesophageal ultrasound‐guided bronchoscopic aspiration
por: Sumi, Toshiyuki, et al.
Publicado: (2021)

Pseudomesotheliomatous Primary Squamous Cell Lung Carcinoma: The First Case Reported in Turkey and a Review of the Literature
por: Katgi, Nuran, et al.
Publicado: (2018)

Rapidly progressive interstitial lung disease due to anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis complicated with cervical cancer: Successful treatment with direct hemoperfusion using polymyxin B-immobilized fiber column therapy
por: Ichiyasu, Hidenori, et al.
Publicado: (2016)

Small Cell Lung Cancer Derived from Adenocarcinoma with Mutant Epidermal Growth Factor Receptor Provides a Signature of Transcriptional Alteration in Tumor Cells
por: Tenjin, Yuki, et al.
Publicado: (2019)

Therapeutic strategies for afatinib‐resistant lung cancer harboring HER2 alterations
por: Torigoe, Hidejiro, et al.
Publicado: (2018)

A Favorable Response to Levetiracetam in a Patient with Metastatic Adenoid Cystic Carcinoma
por: Sakata, Shinya, et al.
Publicado: (2017)

Clinical characteristics of non-small cell lung cancer harboring mutations in exon 20 of EGFR or HER2
por: Takeda, Masayuki, et al.
Publicado: (2018)

Primary lung sebaceous carcinoma successfully treated with radiotherapy and pembrolizumab: A case report
por: Jodai, Yasumiko, et al.
Publicado: (2022)

Anti-tumor effect of neratinib against lung cancer cells harboring HER2 oncogene alterations
por: Ogoshi, Yusuke, et al.
Publicado: (2019)

The rarest of rare cases within the one thousand faces of atypical carcinoid: Pseudomesotheliomatous manifestation in a pregnant woman
por: Kim, Harim, et al.
Publicado: (2021)

Progress in Treatment of Non-Small Cell Lung Cancer Harboring HER2 Aberrations
por: Ni, Jun, et al.
Publicado: (2021)

Clinical Implications and Molecular Characterization of Drebrin-Positive, Tumor-Infiltrating Exhausted T Cells in Lung Cancer
por: Imamura, Kosuke, et al.
Publicado: (2022)

Pseudomesotheliomatous Carcinoma with a High Pleural Hyaluronic Acid Concentration Arising from a Primary Esophageal Squamous Cell Carcinoma
por: Shirahata, Toru, et al.
Publicado: (2019)

Acquisition of the T790M resistance mutation during afatinib treatment in EGFR tyrosine kinase inhibitor–naïve patients with non–small cell lung cancer harboring EGFR mutations
por: Tanaka, Kentaro, et al.
Publicado: (2017)

Acute Exacerbation of Idiopathic Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma after Transcatheter Arterial Therapy Using Miriplatin
por: Kakiuchi, Yosuke, et al.
Publicado: (2019)

Efficacy of multimodal treatment for leptomeningeal metastases in a lung cancer harboring an EGFR mutation
por: Morichika, Daisuke, et al.
Publicado: (2016)

Efficacy of Afatinib in a Previously-Treated Patient with Non-Small Cell Lung Cancer Harboring HER2 Mutation: Case Report
por: Park, Cheol Kyu, et al.
Publicado: (2017)

Afatinib as first‐line treatment for advanced lung adenocarcinoma patients harboring HER2 mutation: A case report and review of the literature
por: Shi, Yuequan, et al.
Publicado: (2018)

Metachronous primary lung adenocarcinomas harboring distinct KRAS mutations
por: Hu, Yan, et al.
Publicado: (2020)

Mutant Proteomics of Lung Adenocarcinomas Harboring Different EGFR Mutations
por: Nishimura, Toshihide, et al.
Publicado: (2020)

Cytological Features of a Variant NUT Midline Carcinoma of the Lung Harboring the NSD3-NUT Fusion Gene: A Case Report and Literature Review
por: Kuroda, Shiho, et al.
Publicado: (2015)

Interstitial lung disease associated with capmatinib therapy in a patient with non‐small cell lung cancer harboring a skipping mutation of MET exon 14
por: Kanemura, Hiroaki, et al.
Publicado: (2020)

Phase I/II Study of Erlotinib to Determine the Optimal Dose in Patients With Non‐Small Cell Lung Cancer Harboring Only EGFR Mutations
por: Takeda, Yuichiro, et al.
Publicado: (2020)

Non-Small Cell Lung Cancer Patients Harboring HER2 Mutations: Clinical Characteristics and Management in a Real-Life Setting. Cohort HER2 EXPLORE GFPC 02–14
por: Auliac, Jean-Bernard, et al.
Publicado: (2019)

A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene
por: Tanaka, Hisashi, et al.
Publicado: (2012)

Clinical benefit from afatinib in an advanced squamous cell lung carcinoma patient harboring HER2 S310Y mutation: a case report
por: Gao, Yan, et al.
Publicado: (2018)

Response to Afatinib in a Patient with Non-Small Cell Lung Cancer Harboring HER2 R896G Mutation: A Case Report
por: Lin, Ling, et al.
Publicado: (2019)

Carcinogen‐induced tumors in SFN‐transgenic mice harbor a characteristic mutation spectrum of human lung adenocarcinoma
por: Kim, Yunjung, et al.
Publicado: (2019)

Afatinib treatment response in advanced lung adenocarcinomas harboring uncommon mutations
por: Li, Teng, et al.
Publicado: (2021)

Diaphragmatic hernia during treatment of lung cancer harboring an EGFR mutation
por: Konno-Yamamoto, Aya, et al.
Publicado: (2021)

The Risks and Benefits of Immune Checkpoint Blockade in Anti-AChR Antibody-Seropositive Non-Small Cell Lung Cancer Patients
por: Saruwatari, Koichi, et al.
Publicado: (2019)

Granulomatosis with polyangiitis can cause periaortitis and pericarditis
por: Miyawaki, Mari, et al.
Publicado: (2017)

Next-generation EGFR/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: a review of the evidence
por: Wang, Xiaochun, et al.
Publicado: (2016)

Poziotinib in Non–Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 Trial
por: Le, Xiuning, et al.
Publicado: (2022)

Successful and Prompt Treatment with Tepotinib for Lung Adenocarcinoma Harboring MET Exon 14 Skipping Mutation Combined with Lung Abscess Formation: A Case Report
por: Makimoto, Go, et al.
Publicado: (2022)

Histological Transformation to Large Cell Neuroendocrine Carcinoma from Lung Adenocarcinoma Harboring an EGFR Mutation: An Autopsy Case Report
por: Moriya, Rika, et al.
Publicado: (2017)

Novel Germline Mutation in the Transmembrane Domain of HER2 in Familial Lung Adenocarcinomas
por: Yamamoto, Hiromasa, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0mgn47ae6nn3uf3h59jv9cmt8r